These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 29729414

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects.
    Pérez-Ruixo JJ, Krzyzanski W, Hing J.
    Clin Pharmacokinet; 2008; 47(6):399-415. PubMed ID: 18479174
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Screen and confirmation of PEG-epoetin β in equine plasma.
    Chang Y, Maylin GM, Matsumoto G, Neades SM, Catlin DH.
    Drug Test Anal; 2011 Jan; 3(1):68-73. PubMed ID: 21254454
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
    Ito Y, Shiroyama K, Yoshimitsu J, Ohashi Y, Sugioka N, Takada K.
    J Control Release; 2007 Aug 28; 121(3):176-80. PubMed ID: 17628163
    [Abstract] [Full Text] [Related]

  • 29. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat.
    Berridge MV, Fraser JK, Carter JM, Lin FK.
    Blood; 1988 Sep 28; 72(3):970-7. PubMed ID: 3416080
    [Abstract] [Full Text] [Related]

  • 30. An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia.
    Veng-Pedersen P, Chapel S, Schmidt RL, Al-Huniti NH, Cook RT, Widness JA.
    Pharm Res; 2002 Nov 28; 19(11):1630-5. PubMed ID: 12458668
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects.
    Pérez-Ruixo JJ, Krzyzanski W, Bouman-Thio E, Miller B, Jang H, Bai SA, Zhou H, Yohrling J, Cohen A, Burggraaf J, Franson K, Davis HM.
    Clin Pharmacokinet; 2009 Nov 28; 48(9):601-13. PubMed ID: 19725594
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin.
    Woo S, Jusko WJ.
    Drug Metab Dispos; 2007 Sep 28; 35(9):1672-8. PubMed ID: 17576810
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
    Souillard A, Audran M, Bressolle F, Jaussaud P, Gareau R.
    Biopharm Drug Dispos; 1996 Dec 28; 17(9):805-15. PubMed ID: 8968532
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.